Lung Cancer Outcomes Boosted By Targeted Therapy
6/04/2013
Thousands of patients with an advanced form of lung cancer that carries a specific dysfunctional gene are likely to fare better if treated with a targeted therapy than with traditional chemotherapy, report Dana-Farber Cancer Institute researchers and a team of international collaborators...
Long-Term Sex Partners Of People With HPV-Related Oral Cancers Not At Increased Risk Of Infection
6/04/2013
Spouses and long-term partners of patients with mouth and throat cancers related to infection with the human papilloma virus (HPV) appear to have no increased prevalence of oral HPV infections, according to results of a multicenter, pilot study led by Johns Hopkins investigators. The study's results suggest that long-term couples need not change their sexual practices, say the scientists...
Personalized Strategies For Pretesting Cervical Tumors
6/04/2013
Doctors at Washington University School of Medicine in St. Louis have shown that testing cervical tumors before treatment for vulnerability to chemotherapy predicts whether patients will do well or poorly with standard treatment. The study supports the future possibility of personalized medicine for cervical cancer, a tumor normally addressed with a one-size-fits-all approach...
Cheap Vinegar Test Detects Cervical Cancer
6/04/2013
A remarkably simple vinegar test in India has managed to lower the rate of cervical cancer deaths by one-third. Healthcare professionals have said that the outcome of the test has been "incredible", stating that it is capable of saving millions of lives...
Cancer Patients In The US Are Suffering From Drug Shortages
6/04/2013
Eighty-three percent of cancer doctors have documented that they have experienced oncology drug shortages. Most of them also say their patients' treatments have been affected, according to a study presented at the 2013 American Society of Clinical Oncology...
Many glioblastoma patients treated with bevacizumab (Avastin®) have significant deterioration in neurocognitive function, symptoms and quality of life. Not only that, the changes often predict treatment outcomes, according to new research from The University of Texas MD Anderson Cancer Center...
Identifying Glioblastoma Patients Most Likely To Benefit From Bevacizumab
6/04/2013
A new test may help identify newly diagnosed glioblastoma patients more likely to benefit from bevacizumab (Avastin®), according to new research from The University of Texas MD Anderson Cancer Center. The results of the study were presented at the annual meeting of the American Society of Clinical Oncology...
No Benefit Offered By Bevacizumab For Newly Diagnosed Glioblastoma
6/04/2013
The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to research led by researchers at The University of Texas MD Anderson Cancer Center...
Symptoms Of Burnout Suffered By Many US Oncologists Despite High Career Satisfaction
6/04/2013
Even though a majority of U.S. oncologists report satisfaction with their careers, many say they have experienced at least one symptom of burnout, a Mayo Clinic-led study has found. The study was released during the American Society of Clinical Oncology's annual meeting in Chicago...
The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to results of a randomized phase III trial, which was presented by a researcher from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania in a plenary session during the American Society of Clinical Oncolo...